Doctor profile · Federal record
Dr. Nadia McFarlane, MD
Psychiatry Physician (CMS: Psychiatry) · Psychiatry Physician · Katy, TX
- NPI 1619175239
- 19 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
633 E Fernhurst Dr Ste 304
Katy, TX 774501586
(346) 361-0100
fax (833) 972-5629
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- June 27, 2025
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 2084P0800X — NUCC code
- State licenses (2)
- Texas #Q7422 · Pennsylvania #MT190580
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1619175239. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$409
Transactions
20
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | 4 | $65.19 | |
| IRONSHORE PHARMACEUTICALS INC. | 3 | $63.26 | |
| Neurocrine Biosciences, Inc. | 2 | $46.76 | |
| Janssen Pharmaceuticals, Inc | 1 | $43.31 | |
| Neos Therapeutics, LP | 2 | $39.29 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37.51 | |
| Corium, LLC | 2 | $28.21 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24.21 | |
| Teva Pharmaceuticals USA, Inc. | 1 | $21.64 | |
| Otsuka America Pharmaceutical, Inc. | 1 | $20.15 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $19.19 |
By nature of payment
Frequently asked questions
What is Dr. Nadia McFarlane's medical specialty?
Dr. Nadia McFarlane practices Psychiatry Physician in Katy, TX.
Where does Dr. Nadia McFarlane practice?
Dr. Nadia McFarlane practices at 633 E Fernhurst Dr Ste 304, Katy, TX 774501586. Office phone: 3463610100.
What is Dr. Nadia McFarlane's NPI?
Dr. Nadia McFarlane's National Provider Identifier (NPI) is 1619175239, issued by NPPES.
Does Dr. Nadia McFarlane accept Medicare assignment?
Dr. Nadia McFarlane does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.